Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.57 |
| ▸ | GNPAT | O15228 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.51 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.51 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.51 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.51 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.51 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.51 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.51 |
| ▸ | GHSR | Q92847 | 1/20 | 0.51 |
| ▸ | FURIN | P09958 | 1/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.49 |
| ▸ | CTSD | P07339 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29438956 | 0.97 | F2 (0.55) | F2GNPATPTPN1PSEN1PSEN2 | |
| SCHEMBL29611822 | 0.93 | F2 (0.61) | F2GNPATPTPN1PSEN1PSEN2 | |
| SCHEMBL30450371 | 0.91 | F2 (0.57) | F2GHSRCTSD | |
| SCHEMBL30120656 | 0.90 | GNPAT (0.58) | F2GNPATPSEN1PSEN2APH1B | |
| SCHEMBL29611454 | 0.86 | PTPN1 (0.60) | F2PTPN1 | |
| SCHEMBL30063477 | 0.86 | F2 (0.53) | F2CTSD | |
| SCHEMBL29429777 | 0.86 | GHSR (0.56) | F2GHSR | |
| SCHEMBL29611881 | 0.86 | F2 (0.59) | F2PTPN1 | |
| SCHEMBL4927118 | 0.86 | FURIN (0.60) | GNPATPTPN1GHSRFURINPTPN2 | |
| SCHEMBL29611951 | 0.85 | BACE1 (0.54) | GNPATPTPN1GHSRFURIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590121-B2 | Peptide compound with repetitive sequences | UNIV KING ABDULLAH SCI & TECH (SA) | 2026-03-31 | — | — | US | disclosed |
| US-12116421-B2 | Peptide-based Dopa containing adhesive gels | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2024-10-15 | — | — | US | disclosed |
| US-20230374069-A1 | PEPTIDE-BASED DOPA CONTAINING ADHESIVE GELS | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2023-11-23 | — | — | US | disclosed |
| EP-4200313-A1 | PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES | King Abdullah University Of Science And Technology (SA) | 2023-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590121-B2 | Peptide compound with repetitive sequences | MEF2D, VIP, IGFBP4 | F2 893/4885GNPAT 4104/4885PTPN1 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.